TipRanks
Moolec Science (MLEC)
NASDAQ:MLEC
US Market
Want to see MLEC full AI Analyst Report?

Moolec Science (MLEC) Ratios

115 Followers

Moolec Science Ratios

MLEC's free cash flow for Q1 2024 was
lt;0.01. For the 2024 fiscal year, MLEC's free cash flow was decreased by $ and operating cash flow was $-0.89. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Jun 23Jun 22
Liquidity Ratios
Current Ratio
― 0.13 1.69 0.42 0.27
Quick Ratio
― 0.12 0.92 0.39 0.27
Cash Ratio
― <0.01 0.66 0.20 0.26
Solvency Ratio
― -0.31 -0.23 -3.70 -1.11
Operating Cash Flow Ratio
― -0.10 -1.14 -0.60 -0.46
Short-Term Operating Cash Flow Coverage
― -0.11 -3.65 -2.95 -15.09
Net Current Asset Value
$ ―$ -256.39M$ -14.22M$ -8.61M$ -3.00M
Leverage Ratios
Debt-to-Assets Ratio
― 1.21 0.42 0.11 0.02
Debt-to-Equity Ratio
― -3.74 2.15 0.26 0.08
Debt-to-Capital Ratio
― 1.36 0.68 0.21 0.07
Long-Term Debt-to-Capital Ratio
― -0.42 0.63 <0.01 0.00
Financial Leverage Ratio
― -3.10 5.10 2.38 3.55
Debt Service Coverage Ratio
― -0.28 -1.37 -19.03 -28.72
Interest Coverage Ratio
― -0.25 -7.76 -41.58 -805.94
Debt to Market Cap
― 6.06 0.03 <0.01 <0.01
Interest Debt Per Share
― 670.02 6.18 1.22 0.05
Net Debt to EBITDA
― -3.57 -1.51 >-0.01 0.26
Profitability Margins
Gross Profit Margin
―34.17%8.40%-15.83%0.00%
EBIT Margin
―-27.36%-127.89%-5730.45%0.00%
EBITDA Margin
―-20.69%-109.50%-5716.97%0.00%
Operating Profit Margin
―-3.14%-160.76%-735.19%0.00%
Pretax Profit Margin
―-50.96%-148.25%-5748.13%0.00%
Net Profit Margin
―-33.41%-129.99%-5722.22%0.00%
Continuous Operations Profit Margin
―-52.95%-129.64%-5722.22%0.00%
Net Income Per EBT
―65.56%87.68%99.55%4825.71%
EBT Per EBIT
―1622.44%92.22%781.86%5.46%
Return on Assets (ROA)
―-54.45%-21.02%-215.33%-79.53%
Return on Equity (ROE)
―168.95%-107.28%-512.46%-282.17%
Return on Capital Employed (ROCE)
―33.43%-33.95%-58.10%-107.00%
Return on Invested Capital (ROIC)
―-5.35%-26.93%-47.32%-99.27%
Return on Tangible Assets
―-86.10%-28.62%-338.92%-414.25%
Earnings Yield
―-273.75%-1.71%-4.08%-1.21%
Efficiency Ratios
Receivables Turnover
― 16.75 3.80 0.54 0.00
Payables Turnover
― 33.83 5.90 0.45 0.00
Inventory Turnover
― 98.23 0.82 2.25 0.00
Fixed Asset Turnover
― 96.81 3.48 0.76 0.00
Asset Turnover
― 1.63 0.16 0.04 0.00
Working Capital Turnover Ratio
― -3.35 -6.74 -0.18 0.00
Cash Conversion Cycle
― 14.72 479.12 29.85 0.00
Days of Sales Outstanding
― 21.80 96.17 682.08 0.00
Days of Inventory Outstanding
― 3.72 444.83 162.16 0.00
Days of Payables Outstanding
― 10.79 61.88 814.39 0.00
Operating Cycle
― 25.51 541.00 844.24 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
― -56.75 -3.64 -3.27 -0.75
Free Cash Flow Per Share
― -69.87 -3.70 -3.35 -0.75
CapEx Per Share
― 13.12 0.06 0.08 0.00
Free Cash Flow to Operating Cash Flow
― 1.23 1.02 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
― -4.33 -58.93 -41.92 0.00
Capital Expenditure Coverage Ratio
― -4.33 -58.93 -41.92 0.00
Operating Cash Flow Coverage Ratio
― -0.10 -0.64 -2.84 -15.09
Operating Cash Flow to Sales Ratio
― -0.07 -1.66 -8.30 0.00
Free Cash Flow Yield
―-73.93%-2.22%-0.61%-0.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
― -0.37 -58.42 -24.49 -82.89
Price-to-Sales (P/S) Ratio
― 0.12 75.94 1.40K 0.00
Price-to-Book (P/B) Ratio
― -0.62 62.68 125.51 233.88
Price-to-Free Cash Flow (P/FCF) Ratio
― -1.35 -45.03 -164.92 -198.96
Price-to-Operating Cash Flow Ratio
― -1.67 -45.79 -168.86 -198.96
Price-to-Earnings Growth (PEG) Ratio
― >-0.01 0.67 -0.02 >-0.01
Price-to-Fair Value
― -0.62 62.68 125.51 233.88
Enterprise Value Multiple
― -4.16 -70.86 -24.52 -102.52
Enterprise Value
― 286.83M 436.48M 1.27B 374.27M
EV to EBITDA
― -4.16 -70.86 -24.52 -102.52
EV to Sales
― 0.86 77.59 1.40K 0.00
EV to Free Cash Flow
― -9.53 -46.01 -164.94 -198.45
EV to Operating Cash Flow
― -11.73 -46.79 -168.87 -198.45
Tangible Book Value Per Share
― -367.01 -0.94 0.58 -1.20
Shareholders’ Equity Per Share
― -153.11 2.66 4.40 0.64
Tax and Other Ratios
Effective Tax Rate
― -0.04 0.13 <0.01 0.00
Revenue Per Share
― 774.28 2.19 0.39 0.00
Net Income Per Share
― -258.69 -2.85 -22.54 -1.81
Tax Burden
― 0.66 0.88 1.00 48.26
Interest Burden
― 1.86 1.16 1.00 0.03
Research & Development to Revenue
― 0.03 0.32 1.49 0.00
SG&A to Revenue
― 0.35 1.16 52.39 0.00
Stock-Based Compensation to Revenue
― 0.01 0.36 48.40 0.00
Income Quality
― 0.22 1.28 0.15 0.42
Currency in USD